Three insights:
1. Agilon is now cleared for use in posterolateral spine procedures when mixed with autograft.
2. The product features a high purity, type 1 fibrillar bovine collagen, which offers a site for cell attachment, migration, proliferation and differentiation.
3. The Irvine, Calif.-based company is accelerating national distribution of Agilon, which is available in three different sizes.
More articles on devices:
Rothman Orthopaedics surgeon to lead orthopedic oncology program
New Southeastern Spine Institute moves closer to completion
Kevin Lobo’s 8+ years as Stryker CEO: Leading 20+ acquisitions, boosting robotics & more
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.